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The Goodpasture antigen is expressed in the human thymus. antibodies. Whereas many glomerular pathologies are
Background. Autoimmunity to kidney antigens causes mem- believed to be caused by autoimmunity to kidney anti-
branous nephropathy and Goodpasture’s disease and very likely gens and are successfully treated with immunosuppres-is pivotal in many other glomerular diseases. We investigated
sion, it is only in Goodpasture’s disease that this hasthe potential for central tolerance to the best-characterized
been demonstrated convincingly. Strong evidence indi-kidney autoantigen, the NC1 domain of the 3 chain of type
IV collagen [3(IV)NC1], which is the target of autoimmune cates that the disease is caused by an autoimmune response
attack in Goodpasture’s disease. to3(IV)NC1 [reviewed in 1] in which3(IV)NC1-specific
Methods. Indirect immunofluorescence on human thymus autoantibodies [2] are pathogenic [3], probably in con-and polymerase chain reaction (PCR) and Southern blot analy-
cert with cellular effector mechanisms [4].sis of cDNA reverse transcribed from RNA extracted from hu-
Pathogenic autoimmunity is infrequent because “cen-man thymus and kidney.
Results. Indirect immunofluorescence on human thymus dem- tral” and “peripheral” mechanisms maintain self-toler-
onstrated the presence of 3(IV)NC1 in all six thymus samples ance. Central tolerance is affected by deletion (negative
examined. The homologous collagen IV chain, 5(IV)NC1, also
selection) in the thymus of T cells that recognize too avidlywas detected with a similar intra-thymic distribution. Strikingly,
self-protein-derived peptides constitutively presented bythymic 3 and 5 localized around and within Hassall’s corpus-
cles in the thymic medulla, which are structures implicated in thymic antigen-presenting cells (APC) [5]. Peripheral
T cell apoptosis and possibly negative selection. In contrast, tolerance is affected by mechanisms that suppress, aner-
1(IV)NC1 localized to the basement membranes of interlobu- gize or delete potentially autopathogenic T cells [6, 7].lar septa and blood vessels, as is typical of collagen IV chains
Since deletion of pathogenic T cells is obviously irrevers-situated outside the thymus. Reverse transcription-polymerase
ible, autoimmunity presumably follows the breakdownchain reaction (RT-PCR) confirmed the presence of mRNA
encoding 3(IV)NC1 and 5(IV)NC1 in thymic tissue estab- of one of the non-deleting forms of peripheral tolerance,
lishing that the antigens were likely to have been synthesized but the relative role in health of central and peripheral
locally.
mechanisms for maintaining tolerance to autoantigensConclusions. The results demonstrate that 3(IV)NC1 is ex-
is not clear. This issue is of particular relevance to kidneypressed in the human thymus, and therefore should be available
for induction of 3(IV)NC1-specific tolerance. This observa- disease, as the number of putatively autoimmune kidney
tion has the important implication that patients’ 3(IV)NC1- diseases suggests that breakdown of self-tolerance to
specific, autoreactive T cells are more likely to recognize cryptic kidney autoantigens is relatively frequent.epitopes that are not adequately presented by thymic antigen-
Until recently, it was widely believed that central toler-presenting cells (APC) than the major antigen-derived epitopes
ance had little role to play in the maintenance of toler-generally identified by conventional approaches.
ance to tissue-specific antigens. This view was based on
the belief that tissue-specific antigens were not available
in the thymus to influence T-cell development. New evi-Goodpasture’s disease is crescentic glomeruloneph-
ritis often with lung hemorrhage associated with tissue- dence suggests that some “tissue-specific” disease-related
deposited and usually circulating NC1 domain of the autoantigens are in fact present in the human thymus,
3 chain of type IV collagen [3(IV)NC1]-specific auto- as had been demonstrated for some experimental auto-
antigens in mouse and rat thymus [8–12]. Beletskaya and
Gnesditskaya have demonstrated that sera from patients
Key words: central and peripheral tolerance, membranous nephropa-
with pemphigus vulgaris bound strongly at the perimeterthy, NC1 domain, type IV collagen, crescentic glomerulonephritis, auto-
immunity. of Hassall’s corpuscles (HC) in the thymic medulla [13].
Pemphigus vulgaris later was shown to be caused by auto-Received for publication December 1, 2000
immunity to desmoglein 3 [14]. More recently, Wakkachand in revised form May 17, 2001
Accepted for publication June 22, 2001 et al were able to immunoprecipitate the -subunit of the
acetylcholine receptor, the target of autoimmune attack in 2001 by the International Society of Nephrology
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myasthenia gravis, from lysates of thymic epithelia cells two nephrectomy specimens. Samples were obtained
after written patient consent and approval by the Lothianextracted from human thymus [15], confirming suspicion
of its presence from early studies showing binding of - Regional Ethics Committee.
Monoclonal antibodies (mAb) MAB3 to 3(IV)NC1bungarotoxin to thymus [16]. Murakami et al demon-
strated thyroid-stimulating hormone (TSH) receptor, the and MAB1 to 1(IV)NC1 were obtained from Wieslab
(Lund, Sweden); their specificities are extensively docu-target of autoimmune attack in Graves disease, by immu-
nostaining of both thymic tissue sections and Western mented [23]. A concentrated preparation of MAB3 was
provided by J. Wieslander. 5(IV)NC1 was stained usingblots of sodium dodecyl sulfate-polyacrylamide gel elec-
trophorsis (SDS-PAGE) treated thymic lysates [17]. Fi- a protein A-concentrated preparation of human serum
from a patient with Alport anti-glomerular basementnally, Pugliese et al used a radioimmunoassay to demon-
strate proinsulin in excess of insulin in human thymus membrane (GBM) disease, as previously reported [24].
as well as mRNA suggesting local production [18]. In
Indirect immunofluorescencethe latter three reports, the authors detected mRNA
transcripts by polymorase chain reaction (PCR), consis- Fresh tissue from thymus or kidney was embedded in
optimal cutting temperature medium and then snap frozentent with intra-thymic transcription and expression of
the tissue-specific autoantigens. Transcripts for a number in liquid nitrogen. Frozen sections were cut on a cryostat,
placed onto microscope slides, and stored at 20C. Theof other tissue-specific antigens have been detected in
thymus in a number of other well-controlled PCR stud- chain-specific mAbs and purified patient’s serum were in-
cubated with the slides overnight at 4C at the followingies. These include transcripts for autoantigens such as
glutamic acid decarboxylase 65, thyroid peroxidase, my- final concentrations: MAB3 1/80 on kidney and concen-
trated MAB3 1/10 on thymus; MAB1 1/80 on kidney andelin basic protein, and thyroglobulin [19]. Taken to-
gether, the evidence requires reappraisal of the role of 1/10 on thymus. Antibody deposition was visualized by
secondary staining with FITC-conjugated goat anti-mousecentral tolerance in autoimmune diseases that target tis-
sue-specific antigens. antibody (1/160 dilution; Sigma) or FITC-conjugated
sheep anti-human antibodies (1/250 dilution; Diagnostics,The role of central mechanisms in tolerance to kid-
ney autoantigens is unknown. The Goodpasture antigen Carluke, Scotland, UK) followed by fluorescence micros-
copy. Control slides were stained with secondary antibod-[3(IV)NC1] is ideal to address this question because it is
a well characterized and clinically relevant kidney auto- ies alone.
antigen with a highly tissue-restricted distribution. In-
RNA extraction and preparation of cDNAdirect immunofluorescence studies of a wide range of
human tissues have demonstrated3(IV)NC1 in the base- Fresh thymus tissue was snap frozen in liquid nitrogen,
crushed into powder using a pestle and mortar, and storedment membranes of only the kidney glomerulus and dis-
tal collecting tubule, the alveolus, the choroid plexus, at80C until use. mRNA was extracted from frozen pow-
dered thymus tissue using the QuickPrepMicro mRNABruch’s membrane and a few other specialized basement
membranes [20, 21]. As well as having a highly restricted purification kit (Amersham Pharmacia Biotech, Buck-
inghamshire, UK). Total RNA was isolated from 0.4 gdistribution, collagen IV is turned over very slowly [22].
Therefore, the rate of presentation of 3(IV)NC1 to pe- portions of fresh or frozen thymus tissue by the phenol-
sodium-acetate-GTC extraction method [25]. RNA sam-ripheral T cells or 3(IV)NC1 leakage to the thymus (as
occurs for blood borne antigens such as albumin) is likely ples (19 L) were treated with 1 L deoxyribonuclease
(DNase; Promega, Madison, WI, USA) for 30 minutesto be very low in health.
This study uses antibodies to 3(IV)NC1, 5(IV)NC1, at 37C to destroy contaminating genomic DNA. DNase
was inactivated by heating to 95C for five minutes.1(IV)NC1 and a range of collagen IV chain transcript-
discriminatory oligonucleotide primers to investigate ex- cDNAs were made from 10 g of total RNA or 1.3 g
of mRNA using reverse transcriptase (RT; Promega).pression in the human thymus of relatively kidney-specific
and widely distributed forms of collagen IV. The results
Polymerase chain reactionconclusively demonstrate 3(IV)NC1 protein and mRNA
in human thymus in quantities very likely are sufficient Oligonucleotide primers were made (Genosys, Wood-
lands, TX, USA) with the sequences shown in Tableto effect tolerance to major 3(IV)NC1 epitopes.
1. The primer sequences were designed to specifically
amplify -actin and portions of the NC1 domains of the
METHODS
1, 3, and 5 chains of collagen IV. Polymerase chain
Materials reactions (PCR) utilized Taq polymerase (Promega) and
standard conditions (1.5 mmol/L Mg2) for 32 cycles,Non-pathological thymus samples were obtained from
six children who were undergoing cardiac operations (Ta- annealing at 55 to 58C and extending at 72C for 90
seconds. More efficient amplification of 5(IV)NC1 wasble 2). Portions of normal kidney were obtained from
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Table 1. Oligonucleotide primer sequences and expected product sizes (in base pairs)
Primers Direction Sequences (5 to 3) Product size
3(IV) Sense CCAGCTGGATCAGATGGATT 992
Antisense TGTGATAGTTCGCTGTTGCC
5(IV) Sense GTCCAGATGGATTGCAAGGT 817
Antisense TTGGGGACAATGAGACACTG
5(IV) Sense CCACAGGGAACACTTCAG 444
inner Antisense CTCTTCCAAGCAGGAACC
-actin Sense CCACCAACTGGGACGACATG 151
Antisense GTCTCAAACATGATCTGGGTCATC
Table 2. Patient demographics and fluorescent micrographs in Figure 1h and j. Stain-
ing for 5(IV)NC1 was detected in all five thymus sam-Patient Age years Diagnosis Race
ples examined and, like 3(IV)NC1, occurred principallyThymus 1 7 Bicuspid aortic valve Caucasian
Thymus 2 2 Ventricular septal defect Caucasian around and within HC with minor staining of the base-
Thymus 3 7 Atrial septal defect Caucasian ment membrane of interlobular septa and blood vessels
Thymus 4 12 Atrial septal defect Caucasian
(Fig. 1b and i). By contrast, 1(IV)NC1 was detected inThymus 5 10 months Ventricular septal defect Caucasian
Thymus 6 16 Atrial septal defect Caucasian a very different distribution in all six thymus samples.
Kidney 1 79 Renal cell carcinoma Caucasian There was strong staining of the basement membranes of
Kidney 2 69 Renal cell carcinoma Caucasian
the interlobular septa and blood vessels (Fig. 1c, k, l) but
negligible localization around HC, even when assessed in
overexposed images in which nonspecific fluorescence out-
lined the HC (Fig. 1k). The pattern of staining for 1(IV)achieved by subjecting the PCR product to further PCR
NC1 exactly echoed the distribution of basal lamina in thewith internal primers (nested PCR), and for this reaction
thymic medulla previously described by electron micro-an extension time of 60 seconds was used. Products were
scopic (EM) ultrastructural analysis [26]. However, theevaluated by agarose gel electrophoresis and by transfer
3(IV)NC1 and much of the 5(IV)NC1 staining wereto nylon membranes followed by hybridization with 32P-
of cells adjacent to HC, or the cellular whorls that com-labeled 3 or 5 cDNA probes.
prised the walls of the HC, and occasional cells/matrixDNA loading was controlled by parallel reactions with
in the center of the HC. Basal laminae are not found in-actin primers. To control for the possibility of DNA
these regions in EM studies [26].contamination, all experiments included control tubes in
Under the conditions used to photograph the slides,which reverse transcriptase was inactivated by heating
we never observed more than minor fluorescence of HCto 95C for two minutes. Because of the similarity of
(less than in Fig. 1k) in slides stained with secondary (anti-collagen IV chains, the chain-specificity of the PCR reac-
mouse or anti-human IgG) antibody alone. Sections of hu-tions was tested by amplification of plasmids containing
man kidney stained with identical procedures gave stain-full-length cDNAs for the NC1 domains of 1, 3, and 5
ing distributions of the three collagen chains (Fig. 1d–f)collagen IV. Products of expected size were only ob-
identical to those reported previously [27], confirming theserved with the specific template.
specificity of the antibodies. Sections stained with second
layer antibodies alone gave negligible staining.
RESULTS
3(IV)NC1, 5(IV)NC1 and 1(IV)NC1 mRNA wereDetails of the patients from whom samples were ob-
detected in the human thymustained are in Table 2.
To assess the potential for intra-thymic production of
3(IV)NC1, 5(IV)NC1 and 1(IV)NC1 protein 3(IV)NC1, as against trapping of 3(IV)NC1 produced
were detected in the human thymus by elsewhere, we sought collagen IV transcripts in thymic
indirect immunofluorescence tissue. Transcripts for 3 or 5 were detected by at least
one of the techniques used in three and five out of sixIndirect immunofluorescence detected 3(IV)NC1 re-
thymus samples, respectively (Table 3). The reactionactivity localized around and within Hassall’s corpuscle
designed to detect 1(IV)NC1 transcripts proved very(HC) in the thymic medulla of all six thymus samples; rep-
inefficient and gave clear results only with control cDNAresentative results are shown in Figure 1a, h, and j. On
and cDNA made from the best RNA preparations. Thethree thymus samples (numbers 2, 4, and 5) the stain-
PCR products could not have arisen from amplificationing was sufficiently strong to outline the structure of HC,
best seen by comparing the light micrograph (Fig. 1g) of genomic DNA as each primer pair amplified across
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Table 3. Identification of 3, 5 and -actin mRNA using sumably due to the low turnover and hence synthesis
polymerase chain reaction (PCR) and Southern blotting rates of collagen IV chains [22].
The finding of 3 and 4 collagen IV chains in humanPCR
thymus is not easily accounted for from what is known of3(IV)NC1 5(IV)NC1 -actin
the function and distribution of collagen IV chains. TheThymus 1 P/x/S –/N/S 
chief extra-thymic localization of collagen IV is to base-Thymus 2 –/x/x –/N/S 
Thymus 3 –/x/x –/N/S  ment membranes where it constitutes a network, typically
Thymus 4 P/x/S P/N/S  appearing in tissue sections as linear staining adjacent toThymus 5 P/x/x P/N/x 
epithelial cells. The basement membranes of most tissuesThymus 6 –/x/x –/–/x 
Kidney 1 –/x/x –/N/S  contain only 1 and 2 chains; the four known other highly
Kidney 2 P/x/x –/N/S  homologous collagen IV chains (3 to 6) occur in a re-
Results are shown for assays by standard PCR/nested PCR/Southern blotting. stricted range of basement membranes in combinationsKey: P, detection by standard PCR; N, detection by nested PCR [5(IV)NC1
only]; S, detection by Southern blotting; –, indicates no detection by that assay; suggestive of distinct networks [28].3(IV)NC1 has been
x indicates assays for which results are not available. The RNA quality clearly identified in a restricted range of basement membranes,varied between the tissues analyzed as the product obtained with -actin primers
varied from just visible () through weak () to strong (). almost all of which have a specialized fluid or dissolved
gas transport function such as that of the glomerulus,
alveolus and choroid plexus. Thus, the thymic distribu-
tion of 3 and 5 chains is atypical, first in that it appears
an intron, and products still were seen when RNA prepa- without basement membranes, and second it localizes
rations were treated with DNAase. Nor could amplifica- around the HC, which has no known fluid transfer func-
tion of contaminating DNA account for the products as
tion. In contrast, the distribution of 1(IV)NC1 along in-
no products were observed in RT-PCR reactions in which
terlobular and vascular basement membranes is entirelyreverse transcriptase was inactivated by heat. Southern
typical of 1 and 2 distribution outside the thymus.blotting confirmed that the products of PCR reactions
It is striking that 3 and 5 localizes in thymus chieflywith 3 primers and 5 primers hybridized efficiently
to HC because this is very similar to the thymic distribu-with 3 and 5 probes. Parallel experiments with RNA
tion reported for acetyl choline receptor [15], TSH recep-extracted from human kidney detected 3(IV)NC1 in
tor [17], and desmoglein 3 [13, 14], all autoantigens thatone out of two kidney samples by PCR, and 5(IV)NC1
are implicated in predominantly antibody-mediated auto-in both kidney samples.
immune diseases. HCs are cystic structures in the thymic
medulla of unknown function that have been implicated
DISCUSSION in T cell apoptosis and possibly selection of T cells [29].
The corpuscles walls are composed of whorls of keratin-The results demonstrate that 3(IV)NC1, the Good-
ized epithelial cells and enclose what appear to be dyingpasture antigen, 5(IV)NC1, the target of Alport anti-
or frankly necrotic cells [reviewed in 30]. The reticuloepi-GBM disease, and 1(IV)NC1 are present in the thymus
thelial cells of HC are metabolically very active, expressof children. Their distribution and the presence in total
a number of important signaling molecules at high levelthymus of mRNA encoding 1, 3 and 5(IV)NC1, sug-
[31, 32], and have extensive cytoplasmic processes thatgests that 3 and 5 collagen IV chains are synthesized
contact cells adjacent in the thymic medulla [33]. Theseby thymic cells in the vicinity of HC, and 1 chains by
include T cells, some of which appear to be undergoingcells lining septal and endothelial basement membranes.
apoptosis [29], abundant B cells, which bear markers ofFailure to detect mRNA for collagen IV chains in all thy-
mus samples positive by immunohistochemistry is pre- activation and rosette with medullary T cells in vitro [34],

Fig. 1. Light microscopy and immunofluorescence of human thymus and kidney. (a–c) Sections of thymus from patient 1 stained with antibodies
to 3(IV), 5(IV), and 1(IV), respectively (original magnification 80). (d–f ) Human kidney stained with antibodies to 3(IV), 5(IV), and
1(IV), respectively. The inferred distribution of collagen IV chains in kidney is identical to previous reports, confirming the specificity of the
antibodies. The other images are higher magnification (160) and show: the light microscopic appearance of a Hassall’s corpuscle (HC) (g); the
distribution of staining for 3(IV) in two thymus samples (h and j); for 5(IV) (i); and for 1(IV) (k, and at 400, l ). 3(IV) and 5(IV) reactivity
localized to cells/matrix in the region immediately bordering HC (compare g and h), and to discrete portions of the wall and interior of HC. The
wall of HC comprises of whorls of keratinizing epithelial cells and the interior comprises macrophages, T cells and often considerable cellular
debris. Our images do not allow precise localization of the 3(IV) and 5(IV) in HC, but are consistent with its occurrence adjacent to or within
individual cells in the periphery, wall or interior of the HC. No basal lamina is seen for HC, as in ultrastructural studies of human thymus [26].
Nonspecific staining of HC did not generate noticeable fluorescence under these photographic conditions, and sections stained with the secondary
antibodies alone appeared black (data not shown). Longer exposures revealed a very different, rather amorphous fluorescence that uniformly
outlined the HC (k). In contrast, 1(IV) was strongly stained in the basement membranes of interlobular septa and blood vessels, but not the
HC. Overexposure sufficient to nonspecifically outline the HC did not detect 1(IV) around HC (k).
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macrophages, and dendritic cells. They also are sites of APPENDIX
strong expression of interleukin-7 (IL-7), transforming Abbreviations used in this article are: 3(IV)NC1, NC1 domain of
growth factor- (TGF-) [35, 36], and Fas [37]. These the 3 chain of type (IV) collagen; APC, antigen-presenting cells;
GBM, glomerular basement membrane; HC, Hassall’s corpuscle; IL,features invite speculation of a specific role of the HC
interleukin; mAb, monoclonal antibodies; mRNA, messenger RNA;in thymic T-cell development. Douek and Altmann have PCR, polymerase chain reaction; RT, reverse transcription; TGF-,
proposed that they are sites where peptides released from transforming growth factor-; TSH, thyroid-stimulating hormone.
dying T cells are recycled for presentation to other T cells
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